CVC Capital Partners

Advantage Solutions named Corporate Champion by the Women’s Forum of New York

Retrieved on: 
Friday, November 10, 2023

IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV), a leading provider of sales and marketing services to consumer goods manufacturers and retailers, today announced that it has been named a “Corporate Champion” by the Women’s Forum of New York .

Key Points: 
  • IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV), a leading provider of sales and marketing services to consumer goods manufacturers and retailers, today announced that it has been named a “Corporate Champion” by the Women’s Forum of New York .
  • The recognition is given to publicly traded companies with a board of directors that is composed of at least 40% women.
  • This year, the group is honoring 233 S&P 500 and Fortune 1000 companies for reaching or surpassing that threshold.
  • “At Advantage, ensuring we have diverse perspectives, backgrounds and experiences is at the heart of the company’s culture, and is a critical factor in our company’s success,” said Dave Peacock, CEO of Advantage Solutions.

Cranemere Names Kamil M. Salame Chief Executive Officer

Retrieved on: 
Wednesday, December 13, 2023

LONDON, Dec. 13, 2023 /PRNewswire/ -- The Cranemere Group ("Cranemere" or the "Firm"), a diversified holding company with permanent capital that allows it to partner with companies for the long term, today announced that Kamil Salame has been named CEO of Cranemere, effective January 22, 2024. Vincent Mai, who founded Cranemere in 2014 and is currently serving as CEO, will continue to serve as the Chairman of the Firm.

Key Points: 
  • Vincent Mai, who founded Cranemere in 2014 and is currently serving as CEO, will continue to serve as the Chairman of the Firm.
  • Salame was most recently a Senior Advisor at CVC Capital Partners.
  • More recently, he led the North American investment activities of CVC Strategic Opportunities, the firm's long-term capital fund.
  • Mr. Salame said, "I am excited to join the Cranemere team.

EQS-News: Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering

Retrieved on: 
Thursday, December 14, 2023

BERKELEY, US – MAINZ, Germany – NOVEMBER 15, 2023 — Mainz Biomed N.V. (Nasdaq: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the closing of its previously announced registered direct offering with several institutional investors to purchase $5.0 million of its ordinary shares (or pre-funded warrants to purchase ordinary shares in lieu thereof) and warrants to purchase ordinary shares.

Key Points: 
  • BERKELEY, US – MAINZ, Germany – NOVEMBER 15, 2023 — Mainz Biomed N.V. (Nasdaq: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the closing of its previously announced registered direct offering with several institutional investors to purchase $5.0 million of its ordinary shares (or pre-funded warrants to purchase ordinary shares in lieu thereof) and warrants to purchase ordinary shares.
  • The combined effective purchase price for each ordinary share (or pre-funded warrant) and associated warrant to purchase one ordinary share was $1.20.
  • Titan Partners Group, a division of American Capital Partners, acted as the sole placement agent for the offering.
  • The registered direct offering was made pursuant to an effective shelf registration statement on Form F-3 (No.

Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering

Retrieved on: 
Wednesday, November 8, 2023

The combined effective purchase price for each share of common stock and associated warrant to purchase one share of common stock will be $0.78.

Key Points: 
  • The combined effective purchase price for each share of common stock and associated warrant to purchase one share of common stock will be $0.78.
  • Under the terms of the securities purchase agreement, Orgenesis has agreed to issue 1,410,256 shares of common stock and warrants to purchase up to an aggregate of 1,410,256 shares of common stock (the “Warrants”).
  • Titan Partners Group, a division of American Capital Partners, is acting as sole placement agent for the offering.
  • The offering is expected to close on or about November 9, 2023, subject to the satisfaction of customary closing conditions.

Number of active GPs in Gulf Cooperation Council doubles as domestic opportunities emerge — Preqin reports

Retrieved on: 
Monday, November 6, 2023

LONDON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Preqin , the global leader in alternative assets data, tools, and insights, published its Private Capital in the Gulf Cooperation Council 2023: Preqin Territory Guide report.

Key Points: 
  • LONDON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Preqin , the global leader in alternative assets data, tools, and insights, published its Private Capital in the Gulf Cooperation Council 2023: Preqin Territory Guide report.
  • The report explores how the alternatives market in the Gulf Cooperation Council (GCC)* is increasingly looking to domestic investment opportunities, beyond oil.
  • Preqin data and insights in the report point to how the GCC is emerging as a potential destination for capital deployment.
  • Furthermore, the 529 active GPs in GCC member countries as of 2023 has nearly doubled from 268 in 2018.

Matt Airhart to Succeed John Damgaard as VelocityEHS CEO

Retrieved on: 
Friday, September 15, 2023

CHICAGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- VelocityEHS ®, the global leader in enterprise EHS & ESG software solutions, announces Matt Airhart, President, will succeed John Damgaard as CEO effective January 1, 2024.

Key Points: 
  • CHICAGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- VelocityEHS ®, the global leader in enterprise EHS & ESG software solutions, announces Matt Airhart, President, will succeed John Damgaard as CEO effective January 1, 2024.
  • A veteran with more than 23 years in the EHS software industry, Airhart has been with VelocityEHS in various leadership roles since co-founding one of the company’s core acquisitions.
  • He has guided this seamless succession plan, skillfully equipping Matt for success in the role of CEO.
  • We thank John for his dedication to meeting his objectives and we look forward to welcoming both Matt and John in their new roles at VelocityEHS,” said Aaron Dupuis, VelocityEHS Chairman and Managing Partner at CVC Capital.

VelocityEHS Expands Board of Directors to Support Strong Growth

Retrieved on: 
Wednesday, August 9, 2023

CHICAGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- VelocityEHS ®, the global leader in enterprise EHS & ESG software solutions, announces it is expanding its Board of Directors to support its continued strong growth.

Key Points: 
  • CHICAGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- VelocityEHS ®, the global leader in enterprise EHS & ESG software solutions, announces it is expanding its Board of Directors to support its continued strong growth.
  • Following the addition of Partners Group alongside CVC Capital as a second major financial sponsor for VelocityEHS in September of 2022, a process began to add two independent Directors to the VelocityEHS Board of Directors.
  • “I am very pleased to announce the appointment of Allison Guidette to our Board of Directors,” said John Damgaard, CEO of VelocityEHS.
  • VelocityEHS is making the world a safer and more sustainable place each day and I believe my experience scaling SaaS businesses and infusing risk management into operational matters is a great fit as VelocityEHS expands its mission to include Safety, Sustainability, and Resiliency.

Asep Inc. Obtains Exclusive Worldwide License from the University of British Columbia for Ground-breaking Medical Device Coating Technology

Retrieved on: 
Wednesday, August 2, 2023

Catheters are an excellent example of medical instruments that can cause serious infections.

Key Points: 
  • Catheters are an excellent example of medical instruments that can cause serious infections.
  • According to the Center for Disease Control and Prevention (CDC), approximately 90% of serious infections caused by catheters are associated with central venous catheters (CVCs).
  • UBC and the non-waiving inventors of the Technology will collectively own the remaining 12% of the issued and outstanding shares of SafeCoat in consideration for the exclusive license grant.
  • Dr. Robert E. W. Hancock, Founder and CEO of Asep Inc., is one of the four non-waiving inventors of the SafeCoat Technology.

Asep Inc. Obtains Exclusive Worldwide License from the University of British Columbia for Ground-breaking Medical Device Coating Technology

Retrieved on: 
Tuesday, August 1, 2023

Catheters are an excellent example of medical instruments that can cause serious infections.

Key Points: 
  • Catheters are an excellent example of medical instruments that can cause serious infections.
  • According to the Center for Disease Control and Prevention (CDC), approximately 90% of serious infections caused by catheters are associated with central venous catheters (CVCs).
  • UBC and the non-waiving inventors of the Technology will collectively own the remaining 12% of the issued and outstanding shares of SafeCoat in consideration for the exclusive license grant.
  • Dr. Robert E. W. Hancock, Founder and CEO of Asep Inc., is one of the four non-waiving inventors of the SafeCoat Technology.

Glendower Capital Raises US$5.8 Billion for Its Fifth Global Secondary Private Equity Fund

Retrieved on: 
Monday, July 31, 2023

Glendower Capital, CVC’s secondaries platform, is pleased to announce the final close of its fifth global secondary private equity fund, Glendower Capital Secondary Opportunities Fund V ("SOF V").

Key Points: 
  • Glendower Capital, CVC’s secondaries platform, is pleased to announce the final close of its fifth global secondary private equity fund, Glendower Capital Secondary Opportunities Fund V ("SOF V").
  • Glendower has raised aggregate capital commitments of US$5.8 billion for the SOF V program to deploy in the secondary market.
  • SOF V is the first fund closed since Glendower completed a strategic merger with CVC in 2022.
  • Glendower operates in the private equity secondaries mid-market, targeting buyout fund investments managed by high quality GPs.